{"database": "lobbying", "table": "lobbying_activities", "rows": [[1892528, "ba98998c-7815-4e33-982d-bfa94450cf4d", "Q3", "BAY BRIDGE STRATEGIES, INC.", 312190, "BIOCRYST PHARMACEUTICALS, INC.", 2016, "third_quarter", "DIS", "Issues related to pandemic preparedness and biodefense. Ebola response. Influenza preparedness. P.L. 114-223, Continuing Appropriations, and Military Construction, Veterans Affairs and Related Agencies Preparedness Act of 2017, and Zika Response Preparedness Act.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2016-10-20T10:27:30.907000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1892528"], "units": {}, "query_ms": 63.859463029075414, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}